PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsLoss of two genes may drive serrated colorectal cancers

BioNews

Loss of two genes may drive serrated colorectal cancers

Published 14 December 2018 posted in News and appears in BioNews 980

Author

Martha Henriques

PET BioNews

Two genetic markers linked to an aggressive, treatment-resistant form of colorectal cancer...

Two genetic markers linked to an aggressive, treatment-resistant form of colorectal cancer.

Serrated tumours are harder to treat than other colorectal cancers, and clinicians frequently struggle to differentiate between serrated and non-serrated tumours. More than a third of colorectal cancers arise from serrated polyps in the colon.

'Our study identified two genetic markers that may clearly identify this colon cancer subgroup and offer an effective precision medicine treatment option,' said study author Dr Darren Sigal, program director of gastrointestinal oncology at Scripps MD Anderson Cancer Center.

The researchers identified the genes in experiments in mice. When mice lacked two genes – which encode protein kinase C lambda/iota and protein kinase C zeta – they spontaneously developed serrated colorectal cancer. Human tissue samples from colorectal cancer patients also showed lowered expression of these proteins compared with samples from cancer-free people.

As well as finding a biomarker for serrated colorectal cancer, the researchers also found a potential treatment combination that could tackle the condition.

Losing the two genes led to a protein called PD-L1 infiltrating the tissue surrounding a serrated tumour. This protein is known to mask cancerous cells from immune cells. When the researchers applied two compounds – TGF-beta receptor inhibitor and anti-PD-L1 – to the tumours, the PD-L1 levels decreased and immune response improved.

'Our findings identify both a promising combination treatment for serrated colorectal cancer and potential biomarkers that can identify this cancer subtype – both of which are urgently needed,' says Dr Jorge Moscat, study author and director and professor in Sanford Burnam Prebys's Cancer Metabolism and Signaling Networks Program.

'Additionally, the mouse model we created closely mirrors the human disease, an important step that could help reveal more insights into this deadly cancer.'

The research was published in the journal Immunity.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
10 September 2021 • 2 minutes read

Gene identified that plays a key role in severity of colon cancer

by Manon Everard

A lack of a specific gene in immune cells of patients with colon cancer has been linked with a much more dangerous form of the disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
18 June 2021 • 2 minutes read

Mutated cells 'hijack ageing gene' to initiate cancer

by Semyon Bodian

A gene associated with ageing may aid precancerous cells in outcompeting healthy stem cells, new research has shown...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 June 2018 • 2 minutes read

Liquid biopsy test offers hope for ten cancers

by Shaoni Bhattacharya

A new blood test which can detect ten cancers at an early stage is offering hope as a way to screen for multiple cancers...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 January 2017 • 2 minutes read

Gene-targeted therapy successful in treating 'undruggable' colon cancer

by Ayala Ochert and 1 others

Researchers have successfully treated a woman with colon cancer using her own immune cells to target a cancer-causing gene that had previously been considered 'undruggable'...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
3 March 2016 • 2 minutes read

Stem cell changes link high-fat diet to colon cancer

by Paul Waldron

A study in mice has shown that a diet high in fat can stimulate the production of stem cells in the intestine, which might then go on to form tumours...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« UK legal system may impact decision to go abroad for surrogacy

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856